Publication: Radiation Treatment for WHO Grade II and III Meningiomas
Open/View Files
Date
2013
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media S.A.
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Walcott, Brian P., Brian V. Nahed, Priscilla K. Brastianos, and Jay S. Loeffler. 2013. “Radiation Treatment for WHO Grade II and III Meningiomas.” Frontiers in Oncology 3 (1): 227. doi:10.3389/fonc.2013.00227. http://dx.doi.org/10.3389/fonc.2013.00227.
Research Data
Abstract
The treatment of meningiomas is tailored to their histological grade. While World Health Organization (WHO) grade I lesions can be treated with either surgery or external beam radiation, WHO Grade II and III lesions often require a combination of the two modalities. For these high-grade lesions, conventional external beam radiation is delivered to either the residual tumor or the surgical resection margin. The optimal timing of radiation, either immediately following surgical resection or at the time of recurrence, is yet to be determined. Additionally, another method of radiation delivery, brachytherapy, can be administered locally at the time of surgery for recurrent lesions. Altogether, the complex nature of WHO grade II and III meningiomas requires careful treatment planning and delivery by a multidisciplinary team.
Description
Other Available Sources
Keywords
Review Article, meningioma, radiosurgery, proton therapy, surgery, brachytherapy
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service